Bayer AG (BAYRY)
BAYRY Stock Price Chart
Explore Bayer AG interactive price chart. Choose custom timeframes to analyze BAYRY price movements and trends.
BAYRY Company Profile
Discover essential business fundamentals and corporate details for Bayer AG (BAYRY) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - General
IPO Date
18 Nov 1996
Employees
90.59K
Website
https://www.bayer.comCEO
William N. Anderson
Description
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.
BAYRY Financial Timeline
Browse a chronological timeline of Bayer AG corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 25 Feb 2026
Upcoming earnings on 11 Nov 2025
EPS estimate is $0.13.
Earnings released on 6 Aug 2025
EPS came in at $0.35 surpassing the estimated $0.25 by +40.00%, while revenue for the quarter reached $12.64B , beating expectations by +30.50%.
Earnings released on 13 May 2025
EPS came in at $0.65 surpassing the estimated $0.63 by +3.17%, while revenue for the quarter reached $15.06B , beating expectations by +12.00%.
Dividend declared on 4 Apr 2025
A dividend of $0.03 per share was announced, adjusted to $0.03. The dividend was paid on 12 May 2025.
Earnings released on 5 Mar 2025
EPS came in at $0.28 matching the estimated $0.28, while revenue for the quarter reached $12.15B , missing expectations by -10.42%.
Earnings released on 12 Nov 2024
EPS came in at $0.07 falling short of the estimated $0.17 by -58.82%, while revenue for the quarter reached $10.93B , missing expectations by -5.21%.
Earnings released on 6 Aug 2024
EPS came in at $0.25 matching the estimated $0.25, while revenue for the quarter reached $11.98B , beating expectations by +4.96%.
Earnings released on 14 May 2024
EPS came in at $0.77 surpassing the estimated $0.42 by +83.33%, while revenue for the quarter reached $14.79B , missing expectations by -7.04%.
Dividend declared on 2 Apr 2024
A dividend of $0.03 per share was announced, adjusted to $0.03. The dividend was paid on 13 May 2024.
Earnings released on 5 Mar 2024
EPS came in at $0.50 surpassing the estimated $0.45 by +11.11%, while revenue for the quarter reached $13.05B , beating expectations by +2.69%.
Earnings released on 8 Nov 2023
EPS came in at $0.10 falling short of the estimated $0.28 by -64.29%, while revenue for the quarter reached $10.91B , missing expectations by -3.55%.
Earnings released on 8 Aug 2023
EPS came in at $0.33 falling short of the estimated $0.39 by -15.38%, while revenue for the quarter reached $12.05B , missing expectations by -8.96%.
Earnings released on 11 May 2023
EPS came in at $0.79 surpassing the estimated $0.55 by +43.64%, while revenue for the quarter reached $15.64B , missing expectations by -1.31%.
Dividend declared on 15 Mar 2023
A dividend of $0.66 per share was announced, adjusted to $0.66. The dividend was paid on 15 May 2023.
Earnings released on 28 Feb 2023
EPS came in at $0.34 surpassing the estimated $0.32 by +6.25%, while revenue for the quarter reached $12.93B , beating expectations by +1.92%.
Earnings released on 8 Nov 2022
EPS came in at $0.29 falling short of the estimated $0.30 by -3.33%, while revenue for the quarter reached $11.02B , beating expectations by +1.81%.
Earnings released on 4 Aug 2022
EPS came in at $0.51 surpassing the estimated $0.46 by +10.87%, while revenue for the quarter reached $13.41B , beating expectations by +6.03%.
Earnings released on 10 May 2022
EPS came in at $0.99 surpassing the estimated $0.78 by +26.92%, while revenue for the quarter reached $16.19B , beating expectations by +9.03%.
Dividend declared on 23 Mar 2022
A dividend of $0.53 per share was announced, adjusted to $0.53. The dividend was paid on 16 May 2022.
Earnings released on 1 Mar 2022
EPS came in at $0.36 surpassing the estimated $0.26 by +38.46%, while revenue for the quarter reached $12.60B , beating expectations by +4.71%.
Earnings released on 9 Nov 2021
EPS came in at $0.31 surpassing the estimated $0.30 by +3.33%, while revenue for the quarter reached $11.35B .
Earnings released on 5 Aug 2021
EPS came in at $0.48 surpassing the estimated $0.47 by +2.13%, while revenue for the quarter reached $12.88B .
Earnings released on 12 May 2021
EPS came in at $0.78 surpassing the estimated $0.77 by +1.30%, while revenue for the quarter reached $14.50B .
Dividend declared on 7 Apr 2021
A dividend of $0.60 per share was announced, adjusted to $0.60. The dividend was paid on 10 May 2021.
Earnings released on 23 Feb 2021
EPS came in at $0.39 matching the estimated $0.39, while revenue for the quarter reached $12.26B .
Earnings released on 3 Nov 2020
EPS came in at $0.24 falling short of the estimated $0.27 by -11.11%, while revenue for the quarter reached $9.99B , beating expectations by +148.50K%.
BAYRY Stock Performance
Access detailed BAYRY performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.